Christine Murray
Consigliere Generale presso CYTOKINETICS, INCORPORATED
Posizioni attive di Christine Murray
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CYTOKINETICS, INCORPORATED | Consigliere Generale | 01/04/2023 | - |
Storia della carriera di Christine Murray
Precedenti posizioni note di Christine Murray
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 07/01/2019 | 15/03/2024 |
| Independent Dir/Board Member | 07/01/2019 | 15/03/2024 | |
| ULTRAGENYX PHARMACEUTICAL INC. | Consigliere Generale | 01/07/2018 | 01/09/2021 |
Raptor Pharmaceuticals, Inc.
 Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Corporate Officer/Principal | 01/01/2015 | 01/02/2017 |
| RAPTOR PHARMACEUTICAL CORP | Consigliere Generale | 01/03/2015 | 01/01/2017 |
| ACHAOGEN | Consigliere Generale | 01/08/2011 | 02/01/2015 |
Formazione di Christine Murray
| The University of Liverpool | Undergraduate Degree |
| Newcastle University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Regno Unito | 3 |
Posizioni
| General Counsel | 4 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 7 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| Aziende private | 3 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Health Technology |
- Borsa valori
- Insiders
- Christine Murray
- Esperienza
